PING-TING LINJAMES CHENG-CHUNG WEIYI-CHIA HUANG2026-10-162026-10-162008-01-01Pure ID: 15213501Pure UUID: c7f0d756-5d50-4fac-878e-6debfc83acb110.1024/0300-9831.78.1.33https://www.scopus.com/pages/publications/48749115959https://scholars.csmu.edu.tw/handle/123456789/31711Few studies have linked homocysteine, B vitamins and/or genetic defects to the risk of hypertension. The purpose of this study was to investigate homocysteine, B-vitamins, and genetic mutation in relation to the risk of hypertension. Subjects were assigned to the hypertension (HTN) group (n=50) or non-hypertension (non-HTN) group (n =123). All subjects' blood pressure (systolic blood pressure, SBP; diastolic blood pressure, DBP), biochemical values, plasma homocysteine, pyridoxal 5'-phosphate (PLP), serum folate, vitamin B12 concentrations, and methylenetetrafolate reductase (MTHFR) 677C→T gene polymorphism were measured. Results showed that subjects with T-allele were positively associated with DBP (β=4.22, p = 0.04) but the significance became weaker (p = 0.06) after homocysteine and B vitamins were additionally adjusted. A significant association of plasma PLP with SBP remained (β = -0.06, p = 0.01) even after homocysteine and T-allele genotypes were additionally adjusted (β = -0.07, p = 0.02). The combined presence of tow PLP (< 30 nmol/L) and carried T-allele enhanced the risk ofhypertension and the risk magnitude was substantially greater (OR, 16.44,p< 0.001). Taken together, the results show that low plasma PLP levels and MTHFR 677C→T genotypes might be significant risk factors for hypertension.8enLow plasma pyridoxal 5′-phosphate concentration and MTHFR 677C → T genotypes are associated with increased risk of hypertensionjournal article